Director at the Brain Imaging Center, McLean Hospital and Professor of Psychiatry, Harvard Medical School researcher to discuss new insights in human brain chemistry.
New York, NY (March 3, 2005) – Kyowa Hakko U.S.A., one of the world leaders in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and functional food products and maker of Cognizin™ brand citicoline, will sponsor an educational seminar at SupplyExpo in Anaheim, CA featuring Cognizin™ and how it may offer new solutions to support optimum cognitive function.
Dr. Perry Renshaw, M.D. and Ph.D., director, Brain Imaging Center, McLean Hospital and Professor of Psychiatry, Harvard Medical School, Belmont, MA, and leading scientific researcher on the health benefits of citicoline, will be the featured speaker at SupplyExpo on Saturday, March 19 from 10:00 to 11:00 a.m in Room 201A at the Anaheim Convention Center. Dr. Renshaw will speak on “The Role of Citicoline in Brain Health.”
Cognizin™, a novel and powerful anti-aging ingredient has been used internationally for the beneficial action toward neurodegenerative disorders associated with stroke, cerebrovascular pathology, brain aging and head trauma. Kyowa Hakko has developed commercial production techniques for citicoline using proprietary fermentation technology. Scientific studies have indicated effectiveness for Alzheimer’s and Parkinson’s disease and improved stroke recuperation, as well as ocular health.
Kyowa Hakko U.S.A. was the recipient of the Nutracon NutrAward for the best new ingredient of 2003 for Cognizin™ awarded at last year’s SupplyExpo.
For more information and reservations call (800) 570-1262 or visit www.cognizin.com. To learn about the complete line of ingredients from Kyowa Hakko visit booth #438.
# # # #
For more information:
Baker Dillon Group